NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Overestimation of plasma level of factor V coagulant activity due to unrecognised preanalytical coagulation.

Author(s): Eschwege V, Trillard M, Robert A

Publication: Thromb Haemost, 2004, Vol. 91, Page 827-8

PubMed ID: 15045150 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of coagulation on prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen concentration, factor II, factor VII + X, and factor V levels in plasma.

Conclusion of Paper

Higher factor V levels were measured in plasma from clotted specimens than non clotted specimens. The increases in factor V levels ranged from 46-335%. PT, APTT, fibrinogen, factor II, and factor VII + X measurements were not affected by initially undetected preanalytical clots.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of coagulation on PT, APTT, fibrinogen, factor II, factor VII + X, and factor V levels in plasma. All specimens were collected in Vacutainers containing citrate. In an effort to evaluate the effects of initially undetected preanalytical clots, specimens with obvious preanalytical clots after centrifugation were not included in the study. Instead, after centrifugation, plasma from specimens with no obvious clots was transferred into new tubes, and the pellets were poured through a gauze swab. Specimens that had a visible clot at this point were included in the study as the clotted specimen (8/1334 or 0.6%), and a second specimen (non clotted) was drawn within 1 day of the first for comparison.

    Summary of Findings:

    Higher factor V levels were measured in the plasma from clotted specimens than non clotted specimens. For the 8 specimen pais included in the study, the increases in factor V levels ranged from 46-335%. PT, APTT, fibrinogen, factor II, and factor VII + X measurements were not affected by initially undetected preanalytical clots.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Morphology Macroscopic observation
    Morphology Hematology/ auto analyzer
    Glycoprotein Hematology/ auto analyzer
    Protein Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Blood and blood products Clotted specimen
    Non clotted specimen

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...